Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome | |
Liu, Hou-Li1; Li, Tian-Tian2; Yu, Ai-Qun3,4; Li, Jingmin5; Li, Xiaoyan5; Li, Lianqin2; Kaifu, Tomonori6 | |
第一作者 | Hou-Li Liu |
通讯作者邮箱 | [email protected] ; [email protected] |
心理所单位排序 | 3 |
摘要 | As a member of peroxiredoxin (PRX) family, PRX3 is predominantly located in mitochondria and plays an important role of free radical scavenging. Since a body of evidence demonstrated the involvement of PRX3 in insulin secretion, insulin sensitivity, and glucose metabolism, the present study was conducted to investigate the role of PRX3 in the pathogenesis of polycystic ovarian syndrome (PCOS) featured in insulin resistance. Enzyme-linked immunosorbent assay was performed to detect plasma PRX3 in PCOS patients and control subjects. Levels of reactive oxygen species (ROS) and oxidized PRXs were detected in mouse islet cells treated with gradient glucose. We did not find significant difference of fasting plasma PRX3 between PCOS patients and controls. No association was noticed between fasting plasma PRX3 and fasting plasma glucose or insulin. After oral glucose tolerance test (OGTT), PCOS patients showed higher levels of both glucose and insulin as compared to controls. The plasma level of PRX3 was significantly increased at 2 h and began to fall back at 3 h of OGTT. There was a one-hour time lag of peak values between plasma PRX3 and insulin, and the plasma PRX3 at 2 h was positively correlated with the insulin level at 1 h of OGTT of PCOS patients. In addition, the level of ROS was significantly elevated at 1 h and oxidized PRX3 was increased dramatically at 2 h of 16.7mM glucose stimulation in mouse islet cells. It seems that PRX3 does not show its antioxidant function under baseline conditions. Instead, PRX3 responds to oxidative stress induced by rapid increase of insulin and glucose in patients with PCOS. |
关键词 | Peroxiredoxin Reactive oxygen species Oxidative stress Polycystic ovarian syndrome Insulin resistance |
2019-03-14 | |
语种 | 英语 |
DOI | 10.1186/s12902-019-0358-3 |
发表期刊 | BMC ENDOCRINE DISORDERS |
ISSN | 1472-6823 |
卷号 | 19页码:6 |
期刊论文类型 | Article |
收录类别 | SCI |
资助项目 | Key Research and Development Program of Shandong Province[2018GSF118190] |
出版者 | BMC |
WOS关键词 | INCREASED OXIDATIVE STRESS ; INSULIN-RESISTANCE ; ANTIOXIDANT DEFENSE ; GLUCOSE-TOLERANCE ; HYPERGLYCEMIA ; PROTECTS ; CRITERIA ; MARKERS ; OBESITY ; CELLS |
WOS研究方向 | Endocrinology & Metabolism |
WOS类目 | Endocrinology & Metabolism |
WOS记录号 | WOS:000461641200001 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.psych.ac.cn/handle/311026/28652 |
专题 | 健康与遗传心理学研究室 |
通讯作者 | Li, Lianqin; Kaifu, Tomonori |
作者单位 | 1.Binzhou Med Univ, Yantai Affiliated Hosp, Dept Lab Med, Yantai 264100, Peoples R China 2.Binzhou Med Univ, Yantai Affiliated Hosp, Dept Reprod Med, 717 Jinbu St, Yantai 264100, Peoples R China 3.Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China 4.Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China 5.Binzhou Med Univ, Sch Basic Med Sci, Yantai 264003, Peoples R China 6.Tohoku Med & Pharmaceut Univ, Div Immunol, Fac Med, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan |
推荐引用方式 GB/T 7714 | Liu, Hou-Li,Li, Tian-Tian,Yu, Ai-Qun,et al. Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome[J]. BMC ENDOCRINE DISORDERS,2019,19:6. |
APA | Liu, Hou-Li.,Li, Tian-Tian.,Yu, Ai-Qun.,Li, Jingmin.,Li, Xiaoyan.,...&Kaifu, Tomonori.(2019).Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome.BMC ENDOCRINE DISORDERS,19,6. |
MLA | Liu, Hou-Li,et al."Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome".BMC ENDOCRINE DISORDERS 19(2019):6. |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
Plasma level of pero(798KB) | 期刊论文 | 作者接受稿 | 限制开放 | CC BY-NC-SA | 请求全文 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论